| [1] |
Demetriou E, Fokou M, Frangos S, et al. Thyroid nodules and obesity[J]. Life (Basel). 2023, 13(6): 1292.
|
| [2] |
Kitahara CM, McCullough ML, Franceschi S, et al. Anthropometric factors and thyroid cancer risk by histological subtype: pooled analysis of 22 prospective studies[J]. Thyroid, 2016, 26(2): 306-318.
|
| [3] |
Fussey JM, Beaumont RN, Wood AR, et al. Does obesity cause thyroid cancer? A mendelian randomization study[J]. J Clin Endocrinol Metab, 2020, 105(7): e2398–2407.
|
| [4] |
Zhao S, Jia X, Fan X, et al. Association of obesity with the clinicopathological features of thyroid cancer in a large, operative population: A retrospective case-control study[J]. Medicine (Baltimore), 2019, 98(50): e18213.
|
| [5] |
Wang H, Wang P, Wu Y, et al. Correlation between obesity and clinicopathological characteristics in patients with papillary thyroid cancer: A study of 1 579 cases: A retrospective study[J]. PeerJ, 2020, 8: e9675.
|
| [6] |
Lee J, Lee CR, Ku CR, et al. Association between obesity and BRAFV600E mutation status in patients with papillary thyroid cancer[J]. Ann Surg Oncol, 2015, 22 Suppl 3: S683-S690.
|
| [7] |
Cnop M, Foufelle F, Velloso LA. Endoplasmic reticulum stress, obesity and diabetes[J]. Trends Mol Med, 2012, 18(1): 59–68.
|
| [8] |
Zheng R, Chen G, Li X, et al. Effect of IL-6 on proliferation of human thyroid anaplastic cancer stem cells[J]. Int J Clin Exp Pathol, 2019, 12(11): 3992-4001.
|
| [9] |
Lumachi F, Basso SM, Orlando R. Cytokines, thyroid diseases and thyroid cancer[J]. Cytokine, 2010, 50(3): 229-233.
|
| [10] |
Couto JP, Daly L, Almeida A, et al. STAT3 negatively regulates thyroid tumorigenesis[J]. Proc Natl Acad Sci USA, 2012, 109(35): E2361-E2370.
|
| [11] |
Sethi JK, Hotamisligil GS. Metabolic messengers: tumour necrosis factor[J]. Nat Metab, 2021, 3(10): 1302-1312.
|
| [12] |
Kobawala TP, Trivedi TI, Gajjar KK, et al. Significance of TNF-α and the adhesion molecules: L-Selectin and VCAM-1 in papillary thyroid carcinoma[J]. J Thyroid Res, 2016: 8143695.
|
| [13] |
Zhang N, Wang Q, Tian Y, et al. Expressions of IL-17 and TNF-α in patients with Hashimoto’s disease combined with thyroid cancer before and after surgery and their relationship with prognosis[J]. Clin Transl Oncol, 2020, 22(8): 1280-1287.
|
| [14] |
Dossus L, Franceschi S, Biessy C, et al. Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: the EPIC study[J]. Int J Cancer, 2018, 142(7): 1332-1342.
|
| [15] |
Gheorghe DC, Stanciu MM, Zamfirescu A, et al. TNF-α may exert different antitumor effects in response to radioactive iodine therapy in papillary thyroid cancer with/without autoimmune thyroiditis[J]. Cancers (Basel), 2021, 13(14): 3609.
|
| [16] |
Haase J, Weyer U, Immig K, et al. Local proliferation of macrophages in adipose tissue during obesity-induced inflammation[J]. Diabetologia, 2014, 57(3): 562–571.
|
| [17] |
Dogan R, Dogan EE, Guler EM, et al. Oxidative stress values of tumor core, edge, and healthy thyroid tissue in thyroid masses[J]. Eur Arch Otorhinolaryngol, 2021, 278(8): 2953–2960.
|
| [18] |
Xing M. Oxidative stress: A new risk factor for thyroid cancer[J]. Endocr Relat Cancer, 2012, 19(1): C7–C11.
|
| [19] |
Bétry C, Challan-Belval MA, Bernard A, et al. Increased TSH in obesity: evidence for a BMI-independent association with leptin[J]. Diabetes Metab, 2015, 41(3): 248-251.
|
| [20] |
Rehem RA, Elwafa WA, Elwafa RA, et al. Study of serum leptin in well-differentiated thyroid carcinoma: correlation with patient and tumor characteristics[J]. World J Surg, 2014, 38(10): 2621-2627.
|
| [21] |
Cheng SP, Chi CW, Tzen CY, et al. Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma[J]. Surgery, 2010, 147(6): 847-853.
|
| [22] |
Uddin S, Bavi P, Siraj AK, et al. Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma[J]. Endocr Relat Cancer, 2010, 17(1): 191-202.
|
| [23] |
Park JW, Han CR, Zhao L, et al. Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model[J]. Endocr Relat Cancer, 2016, 23(1): 53-63.
|
| [24] |
Kim WG, Cheng SY. Mechanisms linking obesity and thyroid cancer development and progression in mouse models[J]. Horm Cancer, 2018, 9(2): 108-116.
|
| [25] |
Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: A review of current evidence[J]. Endocr Rev, 2012, 33(4): 547-594.
|
| [26] |
Zhou Y, Yang Y, Zhou T, et al. Adiponectin and thyroid cancer: insight into the association between adiponectin and obesity[J]. Aging Dis, 2021, 12(2): 597-613.
|
| [27] |
Mitsiades N, Pazaitou-Panayiotou K, Aronis KN, et al. Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies[J]. J Clin Endocrinol Metab, 2011, 96(12): E2023-E2028.
|
| [28] |
Kwon H, Park SE, Yun JS, et al. Serum Adiponectin and progranulin level in patients with benign thyroid nodule or papillary thyroid cancer[J]. Endocrinol Metab (Seoul), 2020, 35(2): 396-406.
|
| [29] |
Finck BN, Johnson RW. Tumor necrosis factor(TNF)-alpha induces leptin production through the p55 TNF receptor[J]. Am J Physiol Regul Integr Comp Physiol, 2000, 278(2): R537-R543.
|
| [30] |
He Y, Lu L, Wei X, et al. The multimerization and secretion of adiponectin are regulated by TNF-alpha[J]. Endocrine, 2016, 51(3): 456-468.
|
| [31] |
Liu J, Xu T, Ma L, et al. Signal pathway of estrogen and estrogen receptor in the development of thyroid cancer[J]. Front Oncol, 2021, 11: 593479.
|
| [32] |
Xing M. Molecular pathogenesis and mechanisms of thyroid cancer[J]. Nat Rev Cancer, 2013, 13(3): 184-199.
|
| [33] |
Xu N, Liu H, Wang Y, et al. Relationship between insulin resistance and thyroid cancer in Chinese euthyroid subjects without conditions affecting insulin resistance[J]. BMC Endocr Disord, 2022, 22(1): 58.
|
| [34] |
Vella V, Malaguarnera R. The emerging role of insulin receptor isoforms in thyroid cancer: clinical implications and new perspectives[J]. Int J Mol Sci, 2018, 19(12): 3814.
|
| [35] |
Manzella L, Massimino M, Stella S, et al. Activation of the IGF Axis in thyroid cancer: implications for tumorigenesis and treatment[J]. Int J Mol Sci, 2019, 20(13): 3258.
|
| [36] |
高琳, 王婧颖, 马素芳, 等. 肠道菌群与甲状腺相关疾病关系的研究进展[J]. 山西医科大学学报, 2023, 54(5): 707-710.
|
| [37] |
Watanabe H, Katsura T, Takahara M, et al. Plasma lipopolysaccharide binding protein level statistically mediates between body mass index and chronic microinflammation in Japanese patients with type 1 diabetes[J]. Diabetol Int, 2020, 11(3): 293-297.
|
| [38] |
Park S, Willingham MC, Qi J, et al. Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer[J]. Endocr Relat Cancer, 2018, 25(10): 865-877.
|